Cryotherapy Business Insurance UK: The Complete Guide for Operators
Why has UK cryotherapy business insurance been transformed in 2026?
For most of the last decade, cryotherapy in the UK was insured as a slightly more interesting variant of standard wellness or aesthetics cover. A contractor's package with treatment risk and equipment cover was usually considered enough. That position no longer holds in 2026 — and the reason is a single 40-second event in Paris in April 2025.
At a sports centre in the 11th arrondissement, a nitrogen leak from a partial-body cryotherapy cabin caused oxygen depletion in the treatment room. A 29-year-old employee supervising the session collapsed and died; the 34-year-old client was hospitalised in critical condition; three further people who attempted rescue were also hospitalised. The French refrigeration regulator and Paris Public Prosecutor's Office opened parallel investigations focused on installation, ventilation, and oxygen monitoring. The incident is widely treated by UK insurers and the British Compressed Gases Association (BCGA) as the modern benchmark event for cryotherapy risk — the cryotherapy industry's equivalent of an Awaab's Law moment for mould remediation.
The downstream effect on UK underwriting has been immediate and consequential. Cryotherapy operators in 2026 face new underwriter expectations: documented compliance with BCGA Code of Practice 36 on cryogenic liquid storage, ATEX-rated oxygen depletion monitoring in any treatment room using liquid nitrogen, written safe systems of work under the Confined Spaces Regulations 1997, fit-tested PPE for cryogenic handling, and DSEAR-aligned ventilation risk assessment. Operators who can evidence these get competitive cover; operators who can't are finding the market hardening or closing entirely.
This guide is the definitive 2026 cryotherapy business insurance article — built around the post-Paris regulatory transformation, the eight distinct claim-driving exposures, the cover architecture that responds, and the operational documentation that makes both compliance and claim defence possible. It complements our alternative therapies business insurance product page and sits within the wider alternative therapies cluster including cold plunge therapy, oxygen therapy, red light therapy, IV drip therapy, and float therapy.
Key facts at a glance
- April 2025 Paris cryotherapy fatality reset UK underwriting expectations — a nitrogen leak from a partial-body cabin killed one employee and critically injured a client; five people hospitalised in total. UK insurers now treat the incident as the benchmark cryogenic event for sector underwriting.
- UK cryotherapy is governed by overlapping non-bespoke regulation — there is no single cryotherapy statute. Operators sit under HSAW 1974, the Confined Spaces Regulations 1997, COSHH 2002, DSEAR 2002, BCGA Codes of Practice, local authority special treatments licensing, and the consumer protection framework. Cover gaps emerge precisely because no single regulator owns the sector.
- Nitrogen-cooled vs electric cryotherapy chambers face materially different risk profiles — nitrogen-based whole-body cryotherapy (WBC) and partial-body cryotherapy (PBC) carry the full asphyxiation and cryogenic handling exposure; electric chambers materially reduce it. Insurance pricing now differentiates clearly between the two.
- Cold burn and frostbite claims dominate the routine PL exposure — temperatures of −110°C to −160°C produce skin contact injuries within seconds where protocols fail. Cover values typically £8k–£60k per incident; severe cases involving permanent tissue damage £40k–£150k+.
- Local authority special treatments licensing applies to most UK cryotherapy premises — under the Local Government (Miscellaneous Provisions) Act 1982 and equivalent local schemes. Operating without the licence voids cover for incidents within scope.
- Cryotherapy insurance premiums in 2026 typically run £2,800–£12,000 for small operators and £8,000–£25,000+ for multi-chamber or mobile facilities. Post-Paris underwriting has compressed the discount market and widened the risk-graded spread.
- Insurance non-disclosure under the Insurance Act 2015 remains the most preventable catastrophe — operating cryotherapy under generic beauty salon or wellness cover without specific declaration leaves treatment, equipment, and catastrophic-event claims uninsured.
1. The 8 biggest cryotherapy risks: summary table
The risks below are ranked by combined frequency, severity, and regulatory consequence under the post-Paris 2026 framework. Some — cold burns, syncope — are routine operational realities. Others — nitrogen asphyxiation, HSE prosecution — are infrequent but business-ending when they occur. The intelligent operator manages all eight simultaneously rather than addressing them in priority order. The same logic appears in our cold plunge therapy insurance guide for sister cold-exposure risk, though cryotherapy's nitrogen exposure adds a catastrophic dimension cold plunge does not carry.
| Risk | Frequency | Severity | Primary Cover |
|---|---|---|---|
| Nitrogen asphyxiation / oxygen depletion | Rare per business | Catastrophic (£500k–£2m+, fatality) | EL + PL + EIL + Legal Expenses |
| Cold burns and frostbite | Common — dominant PL claim | Medium (£8k–£60k typical) | Public Liability with treatment risk |
| Syncope, disorientation, falls | Occasional | Medium-High (£15k–£90k) | Public Liability |
| Client screening failure / cardiovascular events | Rising | High (£40k–£150k+) | PL + Professional Indemnity |
| Equipment breakdown / business interruption | Routine over chamber life | Medium-High (£20k–£120k) | Equipment Breakdown + BI |
| Staff occupational injury / cryogenic handling | Occasional | Medium (£10k–£70k typical) | Employers' Liability |
| ASA therapeutic claims / reputational | Rising | Medium (£5k–£30k + reputational) | PI + Cyber/Media extensions |
| Insurance non-disclosure (IA 2015) | Common (often unnoticed) | Catastrophic (uninsured loss) | None — proposal stage only |
2. How did the Paris cryotherapy fatality reshape UK underwriting?
On 14 April 2025, a partial-body cryotherapy session at a sports centre in Paris's 11th arrondissement ended with an employee dead and a client in critical care. The cause was nitrogen leak from the cabin during operation, causing acute oxygen depletion in the surrounding treatment room. The employee, supervising the session, lost consciousness before being able to evacuate the client; both were found in cardiopulmonary arrest. Three further individuals attempting rescue were also hospitalised. Initial investigation reports identified plumbing work undertaken at the gym earlier in the day as a contributing factor.
The incident matters to UK cryotherapy underwriting for four distinct reasons:
1. It is technically replicable in any UK nitrogen-cooled chamber
The asphyxiation mechanism — liquid nitrogen vaporising into a confined or poorly-ventilated space, displacing ambient oxygen, causing rapid loss of consciousness — applies to every nitrogen-cooled WBC and PBC chamber operating in the UK. 1 litre of liquid nitrogen yields 0.65 m³ of gaseous nitrogen as it vaporises. In a typical UK cryotherapy treatment room of 20–30 m³, a venting incident of even modest scale can drive ambient oxygen concentration below 19.5% (the threshold at which personnel should not enter under EIGA guidance) within minutes. The biology of nitrogen asphyxiation is unforgiving: at oxygen concentrations below 10%, unconsciousness can occur within one or two breaths without prior warning to the victim.
2. UK regulators already had the underlying framework
UK operators are governed by the Confined Spaces Regulations 1997, the Dangerous Substances and Explosive Atmospheres Regulations 2002 (DSEAR), COSHH 2002, and the BCGA Code of Practice 36 on cryogenic liquid storage. The Paris incident didn't create new regulation in the UK — it foregrounded existing regulation that many operators had implicitly under-applied. Post-Paris, HSE and local authority licensing teams have engaged more actively with cryotherapy operators, particularly on oxygen depletion monitoring and ventilation risk assessment.
3. Insurance markets responded with proposal-stage scrutiny
Specialist cryotherapy underwriters now expect proposal-stage evidence of: BCGA-aligned cryogenic storage arrangements; ATEX-rated fixed oxygen depletion monitors in any treatment room using liquid nitrogen; site-specific DSEAR risk assessment; written safe systems of work for nitrogen receipt, transfer, and storage; staff training records aligned to BCGA Guidance Note 11 on managing risk in enclosed workplaces; emergency procedures including evacuation drills. Operators who can evidence these get competitive terms; operators who cannot find premium loadings or refusals.
4. Electric vs nitrogen chamber risk differential now priced explicitly
Electric cryotherapy chambers — which use refrigeration technology rather than nitrogen vaporisation — eliminate the asphyxiation risk entirely. Insurance markets in 2026 increasingly price the differential explicitly, with electric-only operators attracting materially lower premiums for the catastrophic-event component of their cover. Nitrogen-based operators remain the majority of the UK market but face the higher premium and documentation burden.
3. Risk 1: Nitrogen asphyxiation and oxygen depletion — the catastrophic exposure
Nitrogen Asphyxiation — The Catastrophic Cryotherapy Exposure
Nitrogen-cooled cryotherapy chambers use liquid nitrogen at −196°C, which vaporises rapidly into gaseous nitrogen as it cools the chamber. Unlike CO₂ or refrigerant gases, nitrogen is non-toxic, colourless, and odourless — meaning oxygen depletion can develop without any sensory warning to the occupant or operator. Atmospheres containing less than 10% oxygen can cause brain damage and death; asphyxia due to oxygen deficiency is often rapid with no prior warning to the victim. The risk is realised in three typical scenarios: catastrophic chamber leak (as in Paris); cumulative vapour build-up in inadequately ventilated treatment rooms over a session series; and incidents during liquid nitrogen receipt, transfer, or storage where dewars or pipework fail.
Fixed ATEX-rated oxygen depletion monitors in any room handling or using liquid nitrogen, with alarm at 19.5% (warning) and 18% (evacuation); BCGA Code of Practice 36-aligned cryogenic storage with appropriate separation distances and external venting where possible; site-specific DSEAR risk assessment documenting hazardous zones; written safe system of work for nitrogen receipt and transfer; emergency evacuation procedures including no-rescue protocols (the second-victim risk from Paris); mechanical ventilation rated to chamber boil-off plus safety margin; staff training to BCGA standards with documented competency records; oxygen monitoring records reviewed and signed off periodically.
Employers' Liability £10m for operative injury/fatality; Public Liability £5m–£10m with explicit treatment risk and third-party asphyxiation scope; Environmental Impairment Liability for nitrogen release; Legal Expenses with HSE investigation and Corporate Manslaughter scope; Directors and Officers (D&O) liability for individual director defence under Section 37 HSAW 1974. The cover responds where employer duty of care under HSAW 1974 has been met — meaning the documentation evidencing risk assessment, monitoring, training, and emergency procedures is critical to claim defence. HSE prosecution fines for a fatality under the Sentencing Guidelines can reach £450,000+ for micro-companies and £4m+ for medium-sized businesses; criminal fines are uninsurable but defence costs are insurable and routinely £100,000–£300,000.
4. Risk 2: Cold burns and frostbite — the dominant PL claim
Cold Burns and Frostbite — The Routine PL Driver
Whole-body cryotherapy operates at temperatures of −110°C to −160°C; partial-body cryotherapy reaches similar lows. At these temperatures, exposed skin contact with cryogenic vapour or with chamber surfaces produces tissue damage within seconds. Cold burns and frostbite are the dominant routine claim category for UK cryotherapy operators. The typical claim arises from: failure to remove damp or wet items (sweat-damp socks, sports compression wear, moisture on skin) before entry, since moisture conducts cold rapidly and dramatically amplifies tissue damage; insufficient protective wear (cryo gloves, dry socks/booties, ear protection, mouth covering) not issued or not adequately specified; direct contact with chamber walls; or sessions extending beyond the manufacturer-rated maximum duration (typically 2–3 minutes for WBC, 3 minutes for PBC). Claim values £8k–£60k typical; severe cases with permanent tissue damage, scarring, or amputation £40k–£150k+.
Pre-session moisture check documented per client; manufacturer-approved protective wear set (dry cotton socks/booties, cryo gloves, ear protection, mouth covering) issued and confirmed worn at each session; written client briefing on chamber conduct and contact avoidance; documented session duration limits aligned to chamber manufacturer specification; emergency stop protocol with clear sightline to client at all times; periodic chamber surface inspection for ice build-up; first aid trained operator on duty with cold injury response protocols; documented post-session client check.
Public Liability with explicit cryotherapy treatment risk scope. Generic wellness or beauty PL may carry treatment exclusions or pollution sub-limits that won't respond to cold burn claims; specialist cryotherapy placement removes these. Defence depends on documented pre-session protocols, signed client briefing, and protective wear issue records. Documentation is the difference between a £20,000 settlement and a £20,000 successful defence. The same logic applies in our cold plunge therapy insurance guide on the sister cold-exposure modality.
5. Risk 3: Syncope, disorientation, and post-treatment falls
Syncope and Post-Treatment Falls — The Under-Recognised Exposure
Whole-body cryotherapy produces a sharp vasoconstriction-vasodilation response. Blood pressure can drop rapidly in the minutes after chamber exit, particularly in clients who are dehydrated, hypoglycaemic, or unaccustomed to extreme temperature exposure. The resulting syncope (fainting), pre-syncopal lightheadedness, or transient disorientation can produce falls within the cryotherapy facility — onto hard flooring, against chamber surfaces, against treatment room fixtures. The claim profile typically includes head injuries, fractured wrists from instinctive fall-arrest, and occasionally serious injuries where falls occur on stairs or in adjacent gym facilities. Claim values £15k–£90k typical; serious head injury or fracture claims £50k–£200k+.
Pre-session client screening including hydration, recent food intake, and medication status; supervised exit protocol with operator support for first 2–3 minutes post-session; seated recovery area immediately adjacent to chamber; non-slip flooring throughout treatment area with documented anti-slip coefficient; clear signage and stair handrails on any post-session route; protocol for clients reporting dizziness or pre-syncopal symptoms; recovery time minimum before client departure; first aid response capability with documented response times.
Public Liability standard response; defence depends on pre-session screening documentation, supervised exit records, and premises risk assessment. Where the fall occurs in a co-located gym (common for cryotherapy operators sharing premises with fitness facilities) the policy responding may depend on whose premises the fall occurred in — making explicit declaration of the operating model important at proposal. Similar premises-and-treatment overlap issues appear in our personal trainer insurance guidance.
6. Risk 4: Client screening failure and cardiovascular events
Client Screening Failure — The PI Trigger
Cryotherapy is contraindicated in a substantial list of medical conditions: uncontrolled hypertension, cardiovascular disease, recent myocardial infarction or stroke, Raynaud's phenomenon, cold urticaria, cold agglutinin disease, peripheral arterial disease, pregnancy, advanced diabetes with neuropathy, severe anaemia, deep vein thrombosis history, claustrophobia in WBC, and several others. The vasoconstrictive cardiovascular response produced by extreme cold exposure can precipitate myocardial events in undiagnosed or undisclosed cardiac patients. The PI claim profile in 2026 typically alleges that the operator's intake screening was inadequate to identify the contraindication — that a competent operator should have asked specific questions, escalated specific responses, or required GP clearance before proceeding.
Structured pre-treatment medical questionnaire covering all recognised contraindications with explicit yes/no responses; written informed consent specific to cryotherapy including stated contraindications; documented escalation pathway for borderline cases (GP letter, specialist clearance, refusal of treatment); periodic re-screening for repeat clients (medical status changes); operator training in contraindication recognition with documented competency assessment; clear refusal-to-treat policy and documentation; documented response to client misrepresentation (signed acknowledgement that disclosed information is accurate and complete).
Professional Indemnity £500k–£1m responding to screening negligence claims; Public Liability with treatment risk scope responding where the incident is characterised as treatment-related injury rather than advice failure. The distinction matters at claim stage — PI engages for advice/screening, PL engages for treatment-related injury. The documentation evidencing screening — questionnaire, consent form, training records — is the primary defence. Generic wellness PI may not contemplate cryotherapy specifically; specialist placement explicitly covers cryotherapy screening and treatment risk. Run-off PI cover is important because cardiovascular event claims can surface months after a session series ended.
7. Risk 5: Equipment breakdown and business interruption
Equipment Breakdown — The Continuity Risk
Cryotherapy chambers are high-value capital assets — purchase costs range from £25,000 for entry-level partial-body cabins to £120,000+ for premium whole-body chambers. They operate at extreme temperatures and pressures with complex compressor, electrical, and (in nitrogen units) cryogenic systems. Breakdown events are routine across the operational life of a chamber — particularly compressor failure on electric chambers and pipework/dewar/valve failure on nitrogen chambers. Replacement lead times of 8–16 weeks are typical, with bespoke configurations sometimes longer. For an operator whose entire revenue depends on the chamber, this is a business-ending interruption unless properly covered. Combined claim values (equipment repair/replacement + lost revenue + fixed costs during interruption) routinely reach £40k–£120k.
Manufacturer-recommended service schedule documented and adhered to; pressure system inspections per the Pressure Systems Safety Regulations 2000; condition monitoring of compressor and refrigeration plant; documented incident log for any pre-failure indicators; relationship with manufacturer service technician for priority response; pre-arranged backup capacity arrangement with neighbouring operator where feasible; review of business interruption indemnity period at every renewal (12 months minimum; 18–24 months recommended for bespoke equipment).
Equipment Breakdown cover (new-for-old replacement for chambers; mechanical and electrical breakdown for components); Business Interruption cover with indemnity period matched to realistic replacement timescale; Property/Contents cover for the chamber as fixed plant. The common error is BI indemnity period too short — a 12-month period on equipment with 16-week replacement lead time can leave coverage gap during commissioning and ramp-up. Specialist placement matches BI to actual recovery time. Specific declaration of chamber make, model, and value at proposal is essential; generic equipment cover often sub-limits high-value items.
8. Cryotherapy business insurance cover checker
Select your business profile below to see the cover matched to your specific risk profile. For Miller & Partner's main alternative therapies product page see alternative therapies business insurance.
Cryotherapy Business Insurance Cover Checker
Select your business profile to see the recommended insurance programme matched to the 8 main cryotherapy risks
Electric Chamber Studio (Single-Chamber)
- ESSENTIAL Public Liability £5m with treatment risk and cryotherapy specifically declared
- ESSENTIAL Professional Indemnity £500k for screening failure and treatment advice claims
- LEGAL Employers' Liability £10m if any staff (even part-time)
- ESSENTIAL Equipment Breakdown — new-for-old replacement for chamber
- ESSENTIAL Business Interruption — 18-month indemnity period minimum
- ESSENTIAL Property and Contents cover at full replacement value
- RECOMMENDED Cyber insurance — client health data sensitivity
- RECOMMENDED Legal Expenses with regulatory scope (local authority licensing)
- CONSIDER Personal Accident for sole operator income protection
Nitrogen WBC/PBC Studio (Single-Chamber)
- CRITICAL Nitrogen-cooled equipment carries catastrophic-event scope requiring expanded programme
- LEGAL Employers' Liability £10m with cryogenic handling occupational disease scope
- ESSENTIAL Public Liability £5m–£10m with treatment risk and asphyxiation scope
- ESSENTIAL Professional Indemnity £1m with screening failure scope
- ESSENTIAL Environmental Impairment Liability — nitrogen release exposure
- ESSENTIAL Legal Expenses with HSE investigation and Corporate Manslaughter scope
- ESSENTIAL Equipment Breakdown with cryogenic plant specifically declared
- ESSENTIAL Business Interruption — 18-month indemnity period minimum
- ESSENTIAL Documented BCGA/Confined Spaces compliance — see self-check tool below
- RECOMMENDED Directors and Officers (D&O) liability for personal director defence
Multi-Chamber Facility
- CRITICAL Multi-chamber operations elevate equipment risk concentration substantially
- LEGAL Employers' Liability £10m comprehensive scope
- ESSENTIAL Public Liability £10m with treatment risk and (if nitrogen) asphyxiation scope
- ESSENTIAL Professional Indemnity £1m–£2m
- ESSENTIAL Environmental Impairment Liability (if nitrogen)
- ESSENTIAL Equipment Breakdown across all chambers with full schedule
- ESSENTIAL Business Interruption — careful indemnity period calculation; consider partial loss scope
- ESSENTIAL Property and Contents at premises full replacement value
- ESSENTIAL Legal Expenses comprehensive
- ESSENTIAL Cyber insurance comprehensive — multi-chamber client data volume
- ESSENTIAL Directors and Officers (D&O) liability
Gym/Wellness Centre with Cryotherapy
- CRITICAL Co-located operations create complex liability boundaries — declare both activities
- LEGAL Employers' Liability £10m
- ESSENTIAL Public Liability £5m–£10m covering both gym and cryotherapy activities
- ESSENTIAL Cryotherapy specifically declared as additional activity (not assumed within gym cover)
- ESSENTIAL Professional Indemnity covering both fitness instruction and cryotherapy screening
- ESSENTIAL Property and Contents covering combined premises value
- ESSENTIAL Equipment Breakdown including chamber and gym equipment
- ESSENTIAL Business Interruption
- ESSENTIAL Environmental Impairment Liability (if nitrogen chamber)
- RECOMMENDED Cyber insurance covering gym + cryotherapy member data
Mobile Cryotherapy Operator
- CRITICAL Mobile operations face higher premium loading (20-40%) due to variable operating environments
- LEGAL Employers' Liability £10m if any staff
- ESSENTIAL Public Liability £5m–£10m with mobile operations and occupiers' liability extensions
- ESSENTIAL Goods in Transit cover for equipment movement
- ESSENTIAL Commercial vehicle / van insurance with hazardous materials declared (if carrying liquid nitrogen)
- ESSENTIAL Professional Indemnity with screening failure scope
- ESSENTIAL Equipment Breakdown and theft cover for portable chamber
- ESSENTIAL Environmental Impairment Liability (mobile nitrogen carriage)
- ESSENTIAL Business Interruption
- ESSENTIAL Legal Expenses with regulatory scope
Multi-Treatment Clinic Incl. Cryotherapy
- CRITICAL Each treatment modality must be specifically declared — gaps emerge where activities are implied rather than named
- LEGAL Employers' Liability £10m comprehensive
- ESSENTIAL Public Liability £5m–£10m with explicit cover for each modality (cryotherapy, red light, IV drip, oxygen, float, cold plunge as applicable)
- ESSENTIAL Professional Indemnity £1m–£2m covering all modalities
- ESSENTIAL Equipment Breakdown across all therapy equipment
- ESSENTIAL Environmental Impairment Liability (if nitrogen cryotherapy)
- ESSENTIAL Business Interruption comprehensive
- ESSENTIAL Cyber insurance — multi-modality client health data
- ESSENTIAL Legal Expenses comprehensive scope
- RECOMMENDED Directors and Officers (D&O) liability
9. BCGA and confined space readiness self-check
The Paris incident has made BCGA, DSEAR, and Confined Spaces compliance the working benchmark for nitrogen-cooled cryotherapy underwriting in 2026. Tick each compliance discipline your operation has in place. The unchecked items are your priority compliance and insurance gaps. If you operate electric-only chambers, several items still apply (room ventilation, emergency procedures, training) but the cryogenic-specific items are reduced in scope.
BCGA & Confined Space Readiness Self-Check
Click each compliance discipline you have in place. The more ticked, the lower your catastrophic-event exposure and your underwriting premium loading.
-
Fixed ATEX-rated oxygen depletion monitor in any room handling or using liquid nitrogen, with calibrated alarm thresholds (19.5% warning, 18% evacuation)
-
BCGA Code of Practice 36-aligned cryogenic storage — appropriate separation distances, external venting where possible, restricted access
-
Site-specific DSEAR risk assessment documenting hazardous zones, accumulation risks, and control measures
-
Confined Spaces Regulations 1997 risk assessment covering treatment room as enclosed workplace with potential oxygen depletion
-
Written safe system of work for nitrogen receipt and transfer — dewar handling, pipework checks, isolation procedures, leak response
-
Pre-treatment medical screening questionnaire covering all cryotherapy contraindications with explicit yes/no responses and signed acknowledgement
-
Protective wear protocol with documented issue per session — dry cotton socks/booties, cryo gloves, ear protection, mouth covering
-
Emergency evacuation procedure including no-rescue protocol — explicit guidance that staff must not enter compromised atmosphere without breathing apparatus
-
Mechanical ventilation rated to chamber boil-off plus safety margin, with periodic inspection and maintenance records
-
Pressure Systems Safety Regulations 2000 inspections documented and up to date for chamber and ancillary plant
-
Operator training records aligned to BCGA Guidance Note 11 on managing risk in enclosed workplaces, with documented competency assessment per operator
-
Local authority special treatments licence in place where required by local scheme, with documented compliance with licence conditions
-
Insurance specifically declared for cryotherapy and nitrogen handling — written broker confirmation that all your activities are within cover scope
10. Cryotherapy operation risk assessor
Two factors drive cryotherapy operational risk above all others: the equipment type (nitrogen vs electric, single vs multi-chamber) and the maturity of compliance documentation. Use the tool below for your specific risk profile.
Cryotherapy Operation Risk Assessor
Select your equipment configuration and your documentation maturity to see your specific risk profile and indicative insurance package
11. Risk 6: Staff occupational injury and cryogenic handling
Staff Occupational Injury — Cryogenic Handling Exposure
Cryotherapy staff face a distinct cluster of occupational risks beyond the catastrophic asphyxiation scenario. Routine exposures include: cryogenic burns from skin contact with liquid nitrogen during dewar handling, transfer, or chamber priming; cold injuries from prolonged work in or near operating chambers; manual handling injuries from moving heavy dewars (typically 30–50 litres, with full liquid weight 50–80 kg plus dewar weight); slip injuries on icy floor surfaces during defrosting; eye injuries from liquid nitrogen splash; and longer-term respiratory or cardiovascular effects from chronic exposure to cold environments. Most claims sit in the £10k–£70k range; serious cryogenic burns or manual handling back injuries can reach £50k–£150k.
Cryogenic PPE: insulated cryo gloves, face shield/safety goggles, long sleeves, closed-toe footwear; manual handling training with documented competency; mechanical aids for dewar movement (trolleys, lifts) where weight or frequency makes manual handling unsafe; defrosting procedures with documented isolation steps; first aid training including cryogenic burn response; rotation/break protocols for prolonged cold-environment work; documented health surveillance for any staff with significant cold exposure; site-specific COSHH risk assessment covering biological and chemical exposures (cleaning products, nitrogen).
Employers' Liability with explicit cryogenic handling occupational exposure scope. Generic wellness EL may not contemplate cryogenic handling specifically; specialist placement explicitly covers it. The defence depends on documented PPE issue, training records, and risk assessment. The same documentation expectations appear across our specialist therapy guides — see for example our oxygen therapy business insurance guide for sister gas-handling occupational exposure.
12. Risk 7: ASA therapeutic claims and reputational liability
ASA Therapeutic Claims — The Rising Regulatory Exposure
Cryotherapy operators routinely make marketing claims about therapeutic benefit — inflammation reduction, recovery enhancement, weight management support, skin condition improvement, athletic performance, mental health benefit. The Advertising Standards Authority (ASA) and the Committee of Advertising Practice (CAP) Code require that all marketing claims be substantiated by robust evidence appropriate to the claim. Many cryotherapy marketing claims that operators consider standard industry vocabulary actually exceed the substantiated evidence base. The risk profile in 2026 includes: ASA upheld complaints requiring claim retraction (reputational, no direct financial loss but reputational damage and forced marketing rebuild); follow-on consumer claims under the Consumer Protection Act 1987 alleging misleading representations; and (rarely but increasingly) trading standards engagement on health claims.
Marketing claim audit against CAP Code Section 12 (medicines, medical devices, health-related products and beauty products); evidence file substantiating every claim made on website, social media, and physical premises signage; avoidance of medical condition treatment claims unless substantiated; clear distinction between wellness benefit claims (lower evidence bar) and therapeutic claims (higher evidence bar); periodic review of competitor and industry-standard claims for ASA-upheld precedent; written process for marketing approval prior to publication.
Professional Indemnity with media liability extension for marketing claim disputes; Legal Expenses with regulatory scope (ASA, trading standards); Cyber insurance with crisis management/PR extension for reputational fallout from upheld complaints. Standalone ASA fines don't typically apply but the cost of rebuilding marketing materials, retraining staff, and managing PR can reach £15k–£50k. Cover responds where the operator can evidence good-faith attempt to comply — making the marketing audit and evidence file material to claim defence.
13. Risk 8: Insurance non-disclosure under the Insurance Act 2015
Insurance Non-Disclosure — The Most Preventable Catastrophe
The single most common reason UK insurance claims are reduced or declined isn't underwriting fraud or bad luck — it's non-disclosure at the proposal or renewal stage. Cryotherapy operators routinely buy generic beauty salon, wellness, or aesthetics package policies without specifically declaring cryotherapy, nitrogen handling, screening/treatment risk, or co-located activities. The Insurance Act 2015 requires businesses to make a "fair presentation of the risk" — proactively disclosing every material fact the insurer would want to know. Failure to do so allows the insurer to: avoid the policy (treating it as never having existed); reduce the claim proportionally; impose terms that would have applied with proper disclosure.
Annual review of declared activities against actual operations; written confirmation from broker that all current activities are within scope; specific declaration of each work type at proposal (cryotherapy WBC/PBC, equipment type nitrogen vs electric, screening protocols, co-located activities, mobile operations); mid-term notifications to broker when new activities or equipment are added; documented response to broker enquiries at renewal; retention of policy documents and broker correspondence as evidence.
There is no insurance response to insurance non-disclosure — that's the whole point. The cover that should have responded doesn't. The only mitigation is at the proposal stage: detailed declaration, broker discipline, and renewal review. Specialist cryotherapy broker placement makes a material difference here — generic brokers often miss the specific declarations that cryotherapy requires, while specialist brokers know exactly what each insurer expects to see at proposal. For more on the broader principle see our business insurance quote guide.
14. What drives the cost of cryotherapy business insurance in 2026?
Cryotherapy insurance pricing in 2026 reflects the post-Paris underwriting transformation and the genuine claim exposure differential between equipment types. Indicative annual premium ranges:
| Business Profile | Indicative Annual Premium 2026 |
|---|---|
| Electric chamber studio — single unit, £60k–£150k turnover | £2,800–£5,500 |
| Nitrogen PBC studio — single unit, £80k–£180k turnover | £4,500–£8,500 |
| Nitrogen WBC studio — single unit, £100k–£250k turnover | £5,500–£12,000 |
| Multi-chamber facility — mixed equipment, £200k–£600k turnover | £8,500–£18,000 |
| Gym/wellness centre with cryotherapy — co-located, £300k–£800k turnover | £9,000–£20,000 |
| Mobile cryotherapy operator — variable operating environments | £5,500–£14,000 |
| Multi-treatment clinic incl. cryotherapy — full modality range, £400k–£1m+ turnover | £10,000–£25,000+ |
The factors below drive both insurance premium and overall risk management investment. The rating impact within each profile band is typically larger than the differential between profile bands — meaning a nitrogen WBC operator with excellent documentation can pay less than an electric operator with poor documentation.
| Rating Factor | Impact on Premium | What You Can Do |
|---|---|---|
| Equipment type (nitrogen vs electric) | Nitrogen typically 40–80% premium uplift on catastrophic-event component | For new installations evaluate electric chamber options; for nitrogen evidence BCGA compliance |
| BCGA / Confined Spaces documentation maturity | Mature documentation reduces premium 15–25% across programme | Implement oxygen monitoring, DSEAR RA, written safe systems; see self-check tool above |
| Annual turnover and treatment volume | Primary scaling factors for PL, EL, PI | Declare accurately including planned growth and seasonal variation |
| Pre-treatment screening discipline | Documented screening reduces PI premium 10–15% | Structured questionnaire, signed consent, escalation pathway, periodic re-screening |
| Operator training and certification | CIBTAC, VTCT, or manufacturer-aligned training reduces premium 5–10% | Maintain at staff level; evidence at every renewal |
| Limits selected | £5m vs £10m PL material; EIL inclusion adds 8–15% but essential for nitrogen | Match to contract requirements and post-Paris underwriting expectations |
| Claims history | 5+ year impact; cold burn and syncope PL claims particularly material | Root cause analysis and remedial documentation after any claim |
| Co-located vs standalone operation | Co-located gym/wellness premises adds 10–20% | Specific declaration of co-located activities |
| Mobile vs fixed operation | Mobile typically 20–40% premium uplift | Document mobile risk assessment per operating venue type |
| Geographic operating area | Postcode-based loadings for premises and (where mobile) vehicle theft | Declare typical operating area accurately |
| Broker placement | Specialist cryotherapy brokers access better terms than generic placement | Use a broker with specialist alternative therapies underwriting experience |
| Continuity with insurer | 3+ years with same insurer typically reduces renewal premium 5–10% | Strategic continuity decision; don't chase £100 savings |
15. Real claims and how to manage them
Claim — Cold Burn PL, £58,000 Settlement
A small cryotherapy studio operating a nitrogen WBC chamber treated a 38-year-old regular client who had completed approximately 20 prior sessions. The client entered the chamber wearing the studio's standard kit (cryo gloves, dry cotton socks, ear protection, mouth covering). What the operator did not check — and the studio's protocol did not require — was that the client's compression underwear was damp from a pre-session 5km run. During the 3-minute WBC session, moisture in the compression wear conducted cold rapidly, producing significant second-degree cold burn injuries across the upper thighs and lower abdomen. The client required hospital treatment and three weeks off work; minor permanent skin pigmentation changes were left in two areas.
The client brought a PL claim alleging negligent screening (the operator should have asked about pre-session physical activity) and negligent protocol (the studio kit should have included disposable underwear). The studio's documentation review identified that pre-session moisture check was not part of the standard protocol; the consent form did not specifically address pre-session activity; staff training did not cover moisture-driven cold burn risk specifically.
The studio's £5m PL responded. Settlement: £58,000 (medical costs, lost earnings, pain and suffering, future skin treatment, general damages). Defence costs: £12,400. Total claim: £70,400.
Post-claim renewal: PL premium increased 28%. Insurer required: documented pre-session moisture check; pre-session activity questionnaire; disposable underwear option provided as standard; enhanced staff training covering moisture-driven cold burn risk; documented protective wear issue records per session. The studio implemented these and at the following renewal premium returned to an 11% loading over baseline.
The lesson: cold burn is the dominant routine PL claim category for cryotherapy. The documentation that defends these claims — pre-session screening, protective wear issue records, signed acknowledgement of conduct rules — is the same documentation that prevents them. Generic wellness PL often doesn't contemplate cryotherapy-specific cold burn risk; specialist mould PI explicitly covers it.
Claim — Post-Treatment Syncope and Fall, £72,000 Settlement
A 45-year-old client attended a multi-chamber facility for her first cryotherapy session. She completed a WBC session of 2 minutes 30 seconds; the operator monitored throughout and the session concluded normally. The client exited the chamber, reported feeling fine, and walked unassisted to the changing area. Approximately 90 seconds after exit, while changing back into outdoor clothes, she experienced sudden lightheadedness, fell forward, and struck her forehead on the changing room bench. Significant laceration and concussion resulted; she was taken to A&E and required overnight observation plus stitches.
The client brought a PL claim alleging: inadequate post-session supervision (operator should have remained with her for a longer monitoring period); inadequate facility design (changing area should have been within sight of operator; bench should have been padded or rounded); inadequate pre-session screening (the operator should have specifically asked about hydration and breakfast that morning).
The facility's documentation review identified that post-session supervision protocol required operator monitoring for 60 seconds before client departure to changing area — but did not specifically address vasovagal response timing (which can occur 1–3 minutes post-session). Pre-session hydration and meal screening was not part of the standard intake form.
The facility's £10m PL responded. Settlement: £72,000 (medical costs, time off work, ongoing physiotherapy for concussion symptoms, scar revision potential, general damages). Defence costs: £15,800. Total claim: £87,800.
Post-claim renewal: PL premium increased 32%. Insurer required: extended post-session supervision protocol (3 minutes minimum, seated recovery); pre-session hydration and meal questionnaire; facility design review (rounded furniture in changing areas, anti-slip flooring confirmed); first aid response protocol documented and drilled. The facility implemented these and at the following renewal premium returned to a 16% loading over baseline.
The lesson: syncope and post-treatment falls are an under-recognised exposure. The vasovagal response can occur up to 3 minutes after chamber exit — well after most operators consider the session "complete". Extended supervised recovery is the single most effective mitigation, and the documentation of the supervised recovery period is the primary claim defence.
Claim — Equipment Breakdown and Business Interruption, £145,000 Combined
A nitrogen-cooled WBC chamber at a single-chamber studio suffered catastrophic compressor failure during a routine session. The session was safely terminated; no client injury resulted. However, manufacturer inspection identified that the failure had also damaged the cryogenic plumbing within the chamber housing, requiring full plant replacement rather than compressor swap. Replacement chamber lead time: 14 weeks. During the 14-week period, the studio had no operating chamber; it operated 95% of revenue through cryotherapy sessions with limited add-on income from compression therapy and recovery boots.
The studio's Equipment Breakdown cover responded for the chamber replacement: £78,000 (new-for-old replacement of WBC chamber including installation and commissioning). The studio's Business Interruption cover responded for the 14-week revenue loss: £62,000 (lost gross profit calculated against business profile, less compression therapy income retained). Cover-side legal and adjustment costs: £5,200. Total claim: £145,200.
The studio's BI indemnity period was 18 months — well above the 12-month standard often offered. This proved important because the studio chose to upgrade to a higher-specification chamber during replacement, extending commissioning time and adding a 6-week ramp-up period during which session volumes were below historic baseline. The 18-month BI indemnity period covered this ramp-up; a 12-month period would have left the studio uninsured for the final months of recovery.
Post-claim renewal: Equipment Breakdown premium increased 22%, BI premium increased 15%. Insurer required: documented manufacturer service schedule adherence; condition monitoring records; pressure system inspection up to date; emergency response procedure documented.
The lesson: business interruption is the under-funded cover line for cryotherapy operators. The chamber is the business; without it, revenue stops. 12-month BI indemnity is often inadequate for bespoke equipment with long lead times and ramp-up periods. 18-month minimum is the working benchmark; 24 months is appropriate for premium specifications. The cover differential is modest at premium stage; the claim differential is dramatic.
Claims Management Steps
How to respond to a cryotherapy incident or regulatory engagement — the steps below are critical given the multi-policy and multi-regulator exposure typical of 2026 cryotherapy operations:
- Make the site safe and protect persons first. Standard response. For any incident involving oxygen depletion suspicion, evacuate immediately and DO NOT enter the room to attempt rescue without breathing apparatus — the Paris incident demonstrated the second-victim risk. Call 999 and ventilate the area from outside.
- Notify your insurer immediately for any potential claim. Cryotherapy incidents often engage multiple policies (EL, PL, PI, EIL, Legal Expenses, Equipment Breakdown, BI). Single notification triggers coordinated response. Threshold is "may give rise to a claim" — much lower than "formal claim received".
- Preserve all documentation rigorously. Pre-session screening questionnaire; consent form; protective wear issue records; session duration logs; oxygen monitor data (where applicable); chamber service records; staff training records; CCTV footage where available; photographs of incident scene. The documentation pack is the defence across all coverage layers.
- Do not admit liability or fault. Provide factual information about what happened, what protocol was followed. Do not accept fault, apologise in writing, or commit to remedial work that could be interpreted as admission.
- Manage HSE / local authority engagement carefully. If regulators attend or notify, engage your Legal Expenses insurer immediately. Cooperate factually with inspectors but do not provide written statements without legal representation. Regulatory investigation can become criminal prosecution under HSAW 1974 Section 37 (directors personally) or Corporate Manslaughter Act 2007 (companies).
- Notify RIDDOR where reportable. Under the Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013, certain incidents are reportable to HSE within specified timeframes. Fatality, specified injuries, over-7-day incapacitation, and dangerous occurrences (which can include nitrogen release events) all trigger reporting duties.
- Conduct root cause analysis and document remedial action. Identify underlying cause and implement remedial action. Insurers reviewing renewal will ask what's changed since claim; regulators will require evidence of remedial action.
- Update operational documentation to address gap. Where the claim identified a documentation gap (no pre-session screening, no protective wear record, no oxygen monitor record), update the standard operating procedure to close the gap going forward. This is both insurance and regulatory defence.
Glossary of cryotherapy insurance terms
- Whole-Body Cryotherapy (WBC)
- Standing exposure to extreme cold (typically −110°C to −160°C) in a sealed or semi-sealed chamber for 2–4 minutes. Chambers may be nitrogen-cooled (vaporising liquid nitrogen produces cold) or electric (refrigeration plant produces cold). The two equipment types have materially different insurance risk profiles.
- Partial-Body Cryotherapy (PBC)
- Cabin-style exposure where the head remains outside the chamber (cryosauna design). The lower face and head are not exposed to the cold; the body is exposed to nitrogen vapour or chilled air. Typically nitrogen-cooled. The Paris fatality occurred in a PBC cabin.
- BCGA (British Compressed Gases Association)
- UK industry body publishing Codes of Practice and Guidance Notes on the safe use of compressed and cryogenic gases. BCGA Code of Practice 36 governs cryogenic liquid storage at users' premises and is the working benchmark for UK cryotherapy operator nitrogen storage.
- EIGA (European Industrial Gases Association)
- European industry body equivalent to BCGA. Document 44 covers hazards of oxygen-deficient atmospheres; Document 127 covers bulk liquid gas storage. EIGA documents are routinely cited alongside BCGA codes in UK risk assessments.
- Confined Spaces Regulations 1997
- UK regulations requiring suitable and sufficient risk assessment for work in confined spaces, with appropriate controls through a safe system of work. Cryotherapy treatment rooms with potential for oxygen depletion fall within scope; the risk assessment must address the asphyxiation hazard.
- DSEAR 2002 (Dangerous Substances and Explosive Atmospheres Regulations)
- UK regulations governing risks from dangerous substances including those capable of producing oxygen-deficient atmospheres. Requires site-specific risk assessment, classification of hazardous zones, and control measures including ventilation and ignition control.
- COSHH 2002 (Control of Substances Hazardous to Health Regulations)
- UK regulation governing exposure to hazardous substances. For cryotherapy, applies to nitrogen as an asphyxiant, biocidal cleaning chemicals, and any other hazardous substances used in the operation. Imposes duties for risk assessment, exposure control, health surveillance, and training.
- Oxygen Depletion Monitor
- Fixed or portable electronic monitor measuring ambient oxygen concentration, with alarm thresholds typically at 19.5% (warning) and 18% (evacuation). ATEX-rated versions are required where flammable atmosphere risk also exists. Post-Paris, fixed monitors in any liquid nitrogen treatment room are the working insurance standard.
- ATEX
- EU directive (retained in UK law) governing equipment intended for use in potentially explosive atmospheres. ATEX-rated equipment is suitable for use where flammable gas, vapour, or dust hazards exist. Cryotherapy oxygen depletion monitors are typically specified as ATEX-rated for use in zoned areas.
- Treatment Risk Cover
- Specialist insurance scope covering claims arising from the treatment work itself — including cold burn injury, syncope, vasovagal response, screening-related injury, and post-treatment incidents. Generic wellness PL may not contemplate treatment risk specifically; specialist cryotherapy PL explicitly includes it.
- Environmental Impairment Liability (EIL)
- Specialist insurance covering pollution, contamination, and environmental damage. Material for cryotherapy operators handling liquid nitrogen where nitrogen release could affect third-party premises or contribute to oxygen depletion in shared spaces.
- Equipment Breakdown Cover
- Specialist insurance covering mechanical and electrical breakdown of plant and equipment. For cryotherapy, applies to compressor failure, refrigeration plant failure (electric), cryogenic plumbing failure (nitrogen), and ancillary plant breakdown. Typically new-for-old replacement basis with documented service schedule compliance.
- Business Interruption (BI) Insurance
- Cover for lost gross profit and continuing fixed costs during a period of disruption following an insured event. For cryotherapy, the indemnity period should match realistic chamber replacement timescale plus ramp-up — 18 months minimum, 24 months recommended for bespoke equipment.
- Local Authority Special Treatments Licensing
- Licensing scheme under the Local Government (Miscellaneous Provisions) Act 1982 (or London Local Authorities Act in London) requiring licensing of premises providing "special treatments" — typically defined to include cryotherapy. Scheme details vary by local authority; check with environmental health team.
- RIDDOR (Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 2013)
- UK regulations requiring reporting of certain workplace injuries, diseases, and dangerous occurrences to HSE. For cryotherapy, applies to staff cryogenic burns, manual handling injuries, and dangerous occurrences including nitrogen release events.
- Corporate Manslaughter Act 2007
- UK Act creating a corporate manslaughter offence where the way activities are managed or organised by senior management causes death and amounts to a gross breach of duty of care. Unlimited fines and remedial orders. Particularly relevant for nitrogen-cooled cryotherapy where catastrophic events can produce fatalities.
- HSAW 1974 Section 37
- Section 37 of the Health and Safety at Work Act 1974 enabling prosecution of directors personally where an offence was committed with their consent, connivance, or attributable to their neglect. Imprisonment up to 2 years available. D&O cover responds to personal defence costs (criminal fines uninsurable).
Frequently asked questions
Cryotherapy business insurance is specialist commercial insurance designed for whole-body and partial-body cryotherapy operators. The core covers in 2026 are: Public Liability with explicit cryotherapy treatment risk scope; Employers' Liability with cryogenic handling occupational exposure scope; Professional Indemnity with screening failure and treatment advice scope; Equipment Breakdown and Business Interruption for chamber-related disruption; (for nitrogen operators) Environmental Impairment Liability for nitrogen release; Legal Expenses with HSE investigation scope. The cover differs fundamentally from generic beauty salon, aesthetics, or wellness package policies — those typically carry treatment exclusions and don't contemplate cryotherapy specifically.
The April 2025 Paris cryotherapy fatality reset UK insurer expectations for nitrogen-cooled chamber operators. The incident — a nitrogen leak from a partial-body cabin causing employee fatality and client critical injury — demonstrated that the underlying asphyxiation mechanism applies to any nitrogen-cooled operation. UK underwriters now expect proposal-stage evidence of BCGA Code of Practice 36 compliance, fixed ATEX-rated oxygen depletion monitoring, site-specific DSEAR risk assessment, Confined Spaces compliance, and written safe systems of work for nitrogen handling. Operators who can evidence these get competitive cover; operators who cannot find premium loadings or refusals.
Indicative 2026 annual premiums: electric chamber studios £2,800–£5,500; nitrogen PBC studios £4,500–£8,500; nitrogen WBC studios £5,500–£12,000; multi-chamber facilities £8,500–£18,000; gym/wellness centres with cryotherapy £9,000–£20,000; mobile operators £5,500–£14,000; multi-treatment clinics £10,000–£25,000+. Pricing depends on equipment type (nitrogen vs electric), documentation maturity, claims history, limits selected, and broker placement type. Post-Paris underwriting has compressed the discount market and widened the risk-graded spread. See our cold plunge therapy insurance guide for similar specialist therapy pricing principles.
Employers' Liability is legally required if you have staff under the Employers' Liability (Compulsory Insurance) Act 1969 — fines of £2,500 per day for non-compliance. Public Liability is not legally required nationally but is contractually required by virtually all commercial landlords, local authority licensing schemes for special treatments premises, and most professional bodies. Local authority special treatments licensing under the Local Government (Miscellaneous Provisions) Act 1982 typically requires premises licensing with associated insurance evidence. Other covers (PI, EIL, Equipment Breakdown, BI, Legal Expenses) are commercially essential but not legally required.
Nitrogen-cooled chambers use vaporising liquid nitrogen to produce the cold; electric chambers use refrigeration plant. The insurance differential is material. Nitrogen operators face the asphyxiation/oxygen depletion catastrophic-event exposure that requires Environmental Impairment Liability, expanded Legal Expenses, BCGA/DSEAR/Confined Spaces compliance documentation, and typically 40–80% premium uplift on the catastrophic-event component of the cover. Electric chambers eliminate the asphyxiation risk entirely; insurance markets in 2026 price the differential explicitly. For new installations evaluating equipment, the insurance premium differential should be factored into the equipment selection decision alongside performance characteristics.
Only if specifically scoped. Generic beauty or wellness PL may carry treatment exclusions or pollution sub-limits that won't respond to cold burn claims; specialist cryotherapy PL with treatment risk scope explicitly covers cold burn, frostbite, and other cryotherapy-specific injury claims. Get written broker confirmation that treatment risk including cold burn injury is within scope. This is the dominant routine claim category for UK cryotherapy operators. The premium uplift for treatment risk scope is typically modest (£200–£500 on £1m PL); the claim exposure without it is potentially £8k–£60k per claim, or substantially higher for severe cases involving permanent tissue damage.
Yes — particularly under the 2026 framework. PI was historically optional for many cryotherapy operators; post-Paris it has become functionally essential. The claim drivers are: client screening failure (operator failed to identify medical contraindication leading to cardiovascular or other event); treatment advice negligence (recommendations on session frequency, duration, or combination with other therapies); pre/post-treatment guidance failure. Limits typically £500k for small operators; £1m–£2m for multi-chamber facilities or those marketing therapeutic benefit claims. Run-off PI cover is important — cardiovascular event claims can surface months after a session series ended. See our professional indemnity insurance guide for cover principles.
Insurance non-disclosure under the Insurance Act 2015. The pattern: operator buys a beauty salon, aesthetics, or wellness package with "wellness centre" or "beauty treatments" as the declared activity, undertakes cryotherapy as a substantial part of the work, doesn't specifically declare it. At claim stage, the insurer points to the proposal documentation showing the declared activity was generic and a claim involving cold burn, syncope, equipment breakdown, or asphyxiation becomes uninsured. This isn't fraud; it's the normal operation of UK insurance law requiring "fair presentation of the risk". The fix at proposal stage is minimal cost; the retrospective cost is potentially every uninsured claim across multiple policy years. Get written confirmation from your broker that cryotherapy, equipment type, screening protocols, and all specific activities are within scope.
The single biggest premium reduction lever is documented BCGA/DSEAR/Confined Spaces compliance: fixed oxygen depletion monitor with calibration records, BCGA Code of Practice 36-aligned cryogenic storage, site-specific DSEAR risk assessment, written safe systems of work, operator training records aligned to BCGA Guidance Note 11. Mature documentation typically reduces premium 15–25% across the programme. Other levers: CIBTAC/VTCT/manufacturer-aligned operator training; structured pre-treatment screening; accurate activity declaration; limits matched to actual contract requirements; 3+ years continuity with same insurer; annual payment vs monthly; specialist broker placement. Stack the levers; don't choose between them. Avoid the trap of buying the cheapest generic wellness package — the saving is dwarfed by uninsured claim exposure.
Yes, where scoped correctly. Employers' Liability with cryogenic handling scope responds to operative injury or fatality; Public Liability with treatment risk scope responds to third-party (client) asphyxiation injury; Environmental Impairment Liability responds to nitrogen release pollution and contamination spread; Legal Expenses with HSE investigation scope responds to defence costs for HSAW 1974 and Corporate Manslaughter Act prosecutions. Criminal fines are uninsurable under UK public policy, but defence costs are insurable and routinely £100,000–£300,000 for contested HSE prosecution. The cover responds where employer duty of care was met — meaning the documentation evidencing oxygen monitoring, risk assessment, training, and emergency procedures is critical to claim defence. Generic wellness cover almost never contemplates this scenario; specialist cryotherapy placement does.
Each treatment modality must be specifically declared at proposal — gaps emerge where activities are implied within a generic "wellness clinic" or "aesthetics clinic" headline. For a clinic combining cryotherapy with cold plunge, oxygen therapy, red light, IV drip, or float therapy, the typical programme includes: EL £10m; PL £5m–£10m with explicit cover declared for each modality; PI £1m–£2m covering all modalities; Environmental Impairment Liability if nitrogen cryotherapy; Equipment Breakdown across all therapy equipment; Business Interruption; Cyber insurance (multi-modality client health data); Legal Expenses. See our sister cluster guides on IV drip therapy, oxygen therapy, red light therapy, and float therapy for modality-specific cover principles.
Look for brokers with specific experience in alternative therapies, cryotherapy, and cryogenic risk evidenced by: specialist articles or guides on cryotherapy and post-Paris cover scope; willingness to discuss specific exposures (nitrogen asphyxiation, cold burn, screening failure, equipment breakdown) in detail; access to Lloyd's market and specialist MGAs rather than just mainstream commercial markets; FCA authorisation and documented track record. Avoid brokers offering "wellness package" without discussing cryotherapy specifics; brokers who can only quote one or two markets; brokers who don't ask about equipment type and BCGA compliance at proposal. Miller & Partner specialise in this sector — see our alternative therapies main product page and broader alternative therapies insights hub.
Instagram
LinkedIn